ArticleNature communications2026
Development of a split-toxin CRISPR screening platform to systematically identify regulators of human myoblast fusion.
Haifeng Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it